AI Agent Operational Lift for Rti Health Solutions in Durham, North Carolina

Why AI matters at this scale

RTI Health Solutions (RTI-HS) is a specialized contract research organization (CRO) employing 200–500 experts in health economics, epidemiology, and market access. Headquartered in Durham, North Carolina, the firm generates an estimated $60M in annual revenue by delivering evidence-based consulting to pharmaceutical and biotech clients. At this mid-market size, AI adoption is not a luxury but a competitive necessity: the firm’s value lies in the speed and depth of its analytical outputs, and AI can dramatically compress project timelines while improving quality.

What RTI-HS does

RTI-HS designs and executes observational studies, systematic literature reviews, economic models, and real-world evidence analyses to support drug development, regulatory submissions, and payer negotiations. These projects are labor-intensive, relying on teams of highly skilled researchers to manually screen literature, abstract data, and build complex models. The firm’s domain expertise and proprietary datasets are strategic assets that AI can amplify.

Why AI is a strategic lever

For a knowledge-services firm of this scale, AI addresses three critical pain points: (1) capacity constraints—teams can only handle a finite number of concurrent projects, (2) margin pressure—clients expect faster turnarounds at competitive rates, and (3) talent scarcity—experienced health economists are hard to recruit. AI tools can automate up to 40% of routine analytical tasks, freeing senior staff for high-value interpretation and client advisory. Moreover, the firm’s size is ideal: large enough to invest in custom models, yet agile enough to deploy without the bureaucratic inertia of a mega-CRO.

Three concrete AI opportunities with ROI

1. Automated systematic literature review (SLR)
SLRs are the backbone of health economics dossiers. A typical review involves screening 5,000–10,000 abstracts. By fine-tuning a large language model on past reviews, RTI-HS can reduce screening time by 60–70%, saving $200K+ per major project and cutting delivery from months to weeks. The ROI is immediate and measurable.

2. Predictive analytics for real-world evidence
Using machine learning on historical claims and electronic health record data, the firm can build models that forecast treatment patterns, adherence, and outcomes. This shifts the service from descriptive to predictive, enabling clients to simulate market scenarios. A single predictive engagement can command a 30% price premium and deepen client stickiness.

3. AI-assisted health economic modeling
Cost-effectiveness models require populating hundreds of parameters from diverse sources. Natural language processing can extract these from published literature and clinical trial reports, while Bayesian networks can automate sensitivity analyses. This reduces model build time by 50% and minimizes human error, directly improving project margins.

Deployment risks specific to this size band

Mid-market firms face unique risks: talent gap—existing researchers may lack AI skills, requiring upskilling or new hires that strain budgets. Data governance—handling patient-level data demands rigorous compliance; a breach could be catastrophic. Change management—consultants may resist tools they perceive as threatening their expertise. Mitigation requires starting with low-risk, internal-facing use cases, investing in training, and establishing an AI ethics board. A phased approach, beginning with SLR automation, can build momentum and demonstrate value without disrupting client relationships.